Attenuated vaccine-based Rabies virus SAD B19 Bern-C, isolate 9508TCH, BSR-adapted
virus

Attenuated vaccine-based Rabies virus SAD B19 Bern-C, isolate 9508TCH, BSR-adapted

EVAg
Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
014V-02283
Attenuated vaccine-based Rabies virus, 9508TCH, infectivity quantified, BSR-adapted
Product Risk Group: 
RG3
ICTV Taxonomy: 
Riboviria / Orthornavirae / Negarnaviricota / Haploviricotina / Monjiviricetes / Mononegavirales / Rhabdoviridae / Lyssavirus / Rabies lyssavirus
Virus name: 
Rabies virus
Strain: 
SAD B19 Bern-C
Isolate: 
9508TCH

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 vial of 500uL

In stock

1 000,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
BSL3
Virus host type: 
Animal virus
Infectivity Test: 
Detection of Fluorescence Focus Units in BSR cell-line
Viral titer: 
3.9 10^8
Production cell line: 
BSR cell line
Virus Cultivability: 
Cultivable virus
Passage: 
9 passages in BSR cells (2016)
Shipping conditions: 
Dry ice
IATA Classification: 
Category A, UN2814

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Tuesday, 1 January, 1935
Country of collection: 
Czech Republic (the)
Suspected epidemiological origin : 
Czech Republic